PolyCell Technologies

PolyCell Technologies is a biotechnology company that develops proprietary cell-surface modification platforms for diagnostic and therapeutic applications. The company's core technology, known as the PolyCell platform, utilizes specialized molecular linkers to non-covalently attach proteins, such as antibodies and receptors, to the surface of living cells, particularly red blood cells. This approach allows for the creation of functionalized reagent cells used in clinical diagnostics, blood typing, and infectious disease screening. Additionally, the company explores the use of these modified cells as biocompatible vehicles for targeted drug delivery and in vivo imaging. By enabling rapid cell-surface engineering without genetic modification, PolyCell Technologies provides a versatile toolset for both laboratory research and clinical product development.